...gene expression levels without cutting DNA or RNA. Participating in the round were new investor UTokyo Innovation Platform...

...firm’s Remiges BioPharma Fund L.P. came on Feb. 14 with a $10 million investment from UTokyo Innovation Platform...

...close of Remiges BioPharma Fund L.P., bringing the fund's total to $80 million. New LP UTokyo Innovation Platform...